Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT01428154
What this trial is testing

Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney Disease
Amgen
Not applicableEnded earlyNCT04171778
What this trial is testing

Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria

Who this might be right for
Chronic Kidney Disease Stage 3BChronic Kidney Disease, Stage 4Proteinuria
University of Rochester 3
Large-scale testing (Phase 3)Study completedNCT02969655
What this trial is testing

Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)

Who this might be right for
Anaemia
GlaxoSmithKline 271
Early research (Phase 1)Study completedNCT01846468
What this trial is testing

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

Who this might be right for
Chronic Renal Insufficiency
Novartis Pharmaceuticals 205
Large-scale testing (Phase 3)Study completedNCT02680574
What this trial is testing

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
AnemiaNon-Dialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 1,725
Early research (Phase 1)Study completedNCT01763190
What this trial is testing

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Bristol-Myers Squibb 36
Early research (Phase 1)Study completedNCT04699656
What this trial is testing

Plazomicin Study in ESRD Patients Receiving IHD

Who this might be right for
End Stage Renal Disease
Cipla USA Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT00358722
What this trial is testing

An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 44
Testing effectiveness (Phase 2)WithdrawnNCT01343641
What this trial is testing

Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

Who this might be right for
Chronic Kidney DiseaseKidney Disease
University of Virginia
Early research (Phase 1)Study completedNCT07551570
What this trial is testing

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Jiangsu vcare pharmaceutical technology co., LTD 32
Not applicableEnded earlyNCT04434209
What this trial is testing

A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis)

Who this might be right for
SepsisAcute Kidney InjurySeptic Shock
BioMérieux 19
Early research (Phase 1)Study completedNCT05208814
What this trial is testing

Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects

Who this might be right for
Pulmonary Arterial HypertensionErectile Dysfunction
Vigonvita Life Sciences 16
Large-scale testing (Phase 3)Study completedNCT00482599
What this trial is testing

Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT00328692
What this trial is testing

PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

Who this might be right for
Heart Failure, Congestive
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 932
Testing effectiveness (Phase 2)Study completedNCT05285787
What this trial is testing

A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)

Who this might be right for
End-Stage Renal Disease (ESRD)
Epizon Pharma, Inc. 18
Early research (Phase 1)Study completedNCT03947970
What this trial is testing

Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects

Who this might be right for
HemodialysisHealthy
Cara Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT00744341
What this trial is testing

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

Who this might be right for
Acute Decompensated Heart Failure; Renal Dysfunction
Solvay Pharmaceuticals 46
Early research (Phase 1)Study completedNCT04024332
What this trial is testing

Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects

Who this might be right for
Renal InsufficiencyHealthy
Idorsia Pharmaceuticals Ltd. 16
Early research (Phase 1)Study completedNCT04154670
What this trial is testing

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
Ensoma 23
Early research (Phase 1)Study completedNCT01730469
What this trial is testing

Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function

Who this might be right for
Fabry Disease
Amicus Therapeutics 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation